	Ventes		Date
Acadia Pharmaceuticals	USD 284M	5.4M	2025-12
Agios Pharmaceuticals	USD 19.97M	7.07M	2025-12
Akebia Therapeutics	USD 57.34M	10.84M	2025-03
Almirall	EUR 547.63M	12.83M	2025-12
Alnylam Pharmaceuticals	USD 1.1B	150M	2025-12
Amarin	USD 49.67M	23.07M	2025-09
Ardelyx	USD 110.33M	12.67M	2025-09
Astellas Pharma	JPY 571.21B	46.89B	2025-12
AstraZeneca	USD 15.5B	313M	2025-12
Charles River Laboratories	USD 994.2M	5.8M	2025-12
Coherus Biosciences	USD 7.6M	46.54M	2025-03
Emergent BioSolutions	USD 276.6M	6.1M	2023-12
Esperion Therapeutics	USD 51.63M	22.2M	2024-09
Exact Sciences	USD 878.38M	27.38M	2025-12
Halozyme Therapeutics	USD 451.76M	97.76M	2025-12
Incyte	USD 1.51B	140M	2025-12
Ironwood Pharmaceuticals	USD 47.71M	74.35M	2025-12
Karyopharm Therapeutics	USD 30.54M	8.24M	2024-12
Lexicon Pharmaceuticals	USD 1.65M	520K	2024-06
MacroGenics	USD 72.84M	50.6M	2025-09
Moderna	USD 678M	342M	2025-12
Myriad Genetics	USD 209.8M	4.1M	2025-12
Pacira	USD 196.87M	17.35M	2025-12
PTC Therapeutics	USD 164.7M	46.3M	2025-12
Puma Biotechnology	USD 80.54M	33.46M	2024-09
Sarepta Therapeutics	USD 442.9M	43.5M	2025-12
Takeda	JPY 1.19T	80B	2025-12
Ultragenyx Pharmaceutical	USD 207M	47M	2025-12
Vanda Pharmaceuticals	USD 198.77M	151.12M	2024-12

Ironwood Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.